HHS nominee Azar challenged over rising drug prices at company he ran
WASHINGTON — Senate Democrats on Tuesday confronted President Trump’s choice for Health and Human Services secretary — a former top executive at Eli Lilly and Co. — with the jump in price for Lilly’s pharmaceuticals under his tenure. As aides held up…